New initiative aims to transform how Alzheimer’s disease is diagnosed, treated across healthcare settings

Members of the AD-RIDDLE consortium announced today that they will begin a new initiative that aims to bridge the gap between Alzheimer’s research, implementation science, and precision medicine.

IG Live March 29: Maternal Mortality Remains ‘Unacceptably High’

Despite being a high-income country, the U.S. has double the maternal death rate of most other developed nations, with racial disparities exacerbating the crisis. In

March 29, 2024

Marking a vital milestone for Vertex and Charles River

Charles River’s Memphis facility approved to manufacture Vertex’s CASGEVY™ therapy, the world’s first gene-edited therapy targeting severe sickle cell disease

January 9, 2024

NICE rejects Daiichi Sankyo’s Enhertu for breast cancer treatment

Share this article Draft guidance published in September 2023 did not recommend Enhertu for breast cancer patients post-chemotherapy. Credit: ORION PRODUCTION / Shutterstock.com. The UK

March 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.